DRI 56.47 Darden Restaurants $DRI Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
DRI 56.47 Darden Restaurants $DRI Hit a 52 week high of 56.85 Closing the day 09:45 at 56.47 +0.11 +0.20% With a day low of 56.44 and a total volume of 94,126.

DRI Recent Posts: http://investorshangout.com/Darden-Restaurant...DRI-50781/

DRI Darden Restaurants Recent Headline News

Darden Announces Corporate Governance Reforms And Sets Second Quarter Earnings Release For December 16, 2014
PR Newswire - 2 hrs 53 mins ago
Darden Restaurants, Inc. (NYSE: DRI) today announced that, following a comprehensive review of the Company's corporate governance practices, the Board of Directors is implementing a number of reforms designed to ensure that the Company's policies are aligned with shareholder interests and corporate governance best practices. In addition to taking immediate action, the Board has also recommended changes that would require shareholder approval at the company's 2015 Annual Meeting of Shareholders.
DRI: 56.39 (+0.03)

4 S&P 500 Dividend Dogs See 14.5% To 36% November Upsides
Fredrik Arnold - at Seeking Alpha - Thu Nov 13, 3:21AM CST

KMI: 38.64 (+0.11), FTR: 6.76 (-0.02), HCP: 43.76 (+0.46), ED: 62.29 (+0.04), FCX: 28.25 (-0.31), LO: 62.06 (-0.02), PCL: 40.73 (-0.07), COP: 70.27 (-0.93), WIN: 9.76 (+0.07), DRI: 56.39 (+0.03), T: 35.85 (+0.45), COH: 34.93 (-0.23), RIG: 26.35 (-0.73), ESV: 38.13 (-1.14), MAT: 31.23 (-0.08), VZ: 51.09 (+0.27), CTL: 41.09 (+0.59), NE: 21.04 (-0.50)

Final Glance: Restaurant companies
AP - Wed Nov 12, 5:02PM CST
NEW YORK (AP) — Shares of some top restaurant companies were up at the close of trading:
SBUX: 78.33 (+0.48), PZZA: 50.56 (+0.37), CMG: 667.01 (+2.76), DPZ: 92.02 (+0.37), EAT: 55.30 (+0.48), YUM: 75.42 (+0.86), WEN: 8.52 (-0.03), DRI: 56.39 (+0.03)

Midday Glance: Restaurant companies
AP - Wed Nov 12, 12:23PM CST
NEW YORK (AP) — Shares of some top restaurant companies are mixed at 1 p.m.:
SBUX: 78.33 (+0.48), PZZA: 50.56 (+0.37), CMG: 667.01 (+2.76), DPZ: 92.02 (+0.37), EAT: 55.30 (+0.48), YUM: 75.42 (+0.86), WEN: 8.52 (-0.03), DRI: 56.39 (+0.03)

Early Glance: Restaurant companies
AP - Wed Nov 12, 10:05AM CST
NEW YORK (AP) — Shares of some top restaurant companies are mixed at 10 a.m.:
SBUX: 78.33 (+0.48), PZZA: 50.56 (+0.37), CMG: 667.01 (+2.76), DPZ: 92.02 (+0.37), EAT: 55.30 (+0.48), YUM: 75.42 (+0.86), WEN: 8.52 (-0.03), DRI: 56.39 (+0.03)

Alibaba and Ford are big market movers
AP - Tue Nov 11, 3:30PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
F: 15.01 (+0.43), SFY: 6.00 (+0.06), THLD: 3.12 (-0.02), SFM: 30.22 (+0.14), ZNGA: 2.83 (+0.02), LUV: 39.67 (+0.30), DRI: 56.39 (+0.03), BABA: 116.49 (-1.71)

Heat join competitive workforce coalition
AP - Tue Nov 11, 11:32AM CST
MIAMI (AP) — The parent company of the Miami Heat and AmericanAirlines Arena is joining a coalition that provides stronger nondiscrimination protections for the gay and transgender community.
RJF: 56.97 (-0.08), DRI: 56.39 (+0.03)

Darden Restaurants (DRI) Stock Gains Today Following Analyst Upgrade
at The Street - Tue Nov 11, 8:39AM CST
Darden Restaurants (DRI) shares are climbing after the company's shares were upgraded to 'buy' from 'hold' by analysts at KeyBanc.
DRI: 56.39 (+0.03)

Upgrade Alert for Darden Restaurants (DRI)
Comtex SmarTrend(R) - Tue Nov 11, 7:02AM CST
Darden Restaurants (NYSE RI) was upgraded from Hold to Buy at Keybanc today. The stock closed yesterday at $54.31 on volume of 1.9 million shares, below average daily volume of 1.9 million. Darden Restaurants (NYSE RI) is currently priced 6.7% above its average consensus analyst price target of $50.65. Darden Restaurants shares have support at the 50-day moving average (MA) of $50.18 and additional support at the 200-day MA of $48.95.
DRI: 56.39 (+0.03)

KeyCorp backs Darden transformation
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 6:47AM CST

DRI: 56.39 (+0.03)

After Yesterday's Rally of 1.51% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 10, 4:45PM CST
Darden Restaurants (NYSE RI) traded in a range yesterday that spanned from a low of $53.23 to a high of $54.32. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $53.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DRI: 56.39 (+0.03)

Darden Restaurants Rises 1.51% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Nov 10, 4:45PM CST
Darden Restaurants (NYSE RI) traded in a range yesterday that spanned from a low of $53.23 to a high of $54.32. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $53.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DRI: 56.39 (+0.03)

Cramer's Mad Money - 8 Earnings To Watch This Week (11/7/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Nov 09, 7:58AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program , Friday November 7. Earnings to watch this week: WhiteWave (NYSE: WWAV ), D.R Horton (NYSE: DRI ), Macy's (NYSE: M ), J.C. Penney (NYSE: JCP ), Cisco (NASDAQ: CSCO...
WWAV: 36.34 (+0.30), KSS: 56.00 (-1.91), JCP: 7.05 (-0.71), JWN: 73.01 (+0.16), WMT: 82.03 (+2.83), M: 60.76 (-0.81), EPR: 56.81 (+0.22), HSIC: 130.39 (+0.71), CSCO: 25.76 (+0.65), DRI: 56.39 (+0.03)

Why I Haven't Sold My ARCP Shares... Yet
Nicholas Ward - at Seeking Alpha - Thu Nov 06, 4:55PM CST

RCAP: 10.04 (-1.55), NNN: 38.46 (+0.10), ARCP: 8.85 (+0.06), O: 46.60 (+0.26), DRI: 56.39 (+0.03)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading